MREO vs VRTX: Which Stock is Better?

Side-by-side comparison of Mereo BioPharma Group PLC ADR and Vertex Pharmaceuticals Inc in 2026

Comparison Updated:

MREO

Mereo BioPharma Group PLC ADR

VRTX

Vertex Pharmaceuticals Inc

$446.83

Key Metrics Comparison

MetricMREOVRTXWinner
Market Cap$49.99M$106.87BVRTX
P/E RatioN/A29.67VRTX
EPS (TTM)$N/A$N/ATie
Revenue Growth0.0%0.0%Tie
Gross Margin0.0%0.0%Tie

Analyze MREO

Full quant analysis

Analyze VRTX

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is MREO or VRTX a better investment?

Comparing MREO and VRTX: Mereo BioPharma Group PLC ADR has a market cap of $49.99M while Vertex Pharmaceuticals Inc has $106.87B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between MREO and VRTX?

MREO (Mereo BioPharma Group PLC ADR) and VRTX (Vertex Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: MREO or VRTX?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: MREO or VRTX?

Both MREO and VRTX show similar growth rates. Check our detailed analysis for quarterly trends.

Which company is more profitable: MREO or VRTX?

Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.

Which is the larger company: MREO or VRTX?

Vertex Pharmaceuticals Inc (VRTX) is larger with a market cap of $106.87B compared to $49.99M for MREO.

Should I buy MREO or VRTX in 2026?

Both MREO and VRTX have investment merit. MREO trades at $N/A while VRTX trades at $446.83. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between MREO and VRTX stock?

Key differences: Market Cap ($49.99M vs $106.87B), P/E Ratio (N/A vs 29.7x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).

Should I buy MREO or VRTX in 2026?

The choice between MREO and VRTX depends on your investment goals. VRTX shows higher revenue growth (0.0%). VRTX has better margins (0.0%). Consider your risk tolerance and time horizon.

What is the market cap comparison between MREO and VRTX?

MREO (Mereo BioPharma Group PLC ADR) has a market cap of $49.99M, while VRTX (Vertex Pharmaceuticals Inc) has a market cap of $106.87B. VRTX is the larger company by market value.

Popular Stock Comparisons